Matthews China Active ETF (MCH)

The most compelling aspect of this instrument is its dramatic recent recovery, which has erased nearly two years of losses in a single year. After suffering double-digit declines in 2023 and 2024, the asset surged nearly 50% in the trailing twelve months, driven by a rebound in Chinese equities and active management outperformance. This sharp reversal suggests the market has priced in a significant correction, leaving the current valuation attractive relative to the recent low. However, the short-term outlook remains cautious; the price is currently hovering just below its 50-day moving average, indicating that the recent rally has stalled rather than accelerating into a new trend. With volume running slightly below the average, there is no immediate surge of capital flowing in to push the price higher, suggesting the recent gains may be consolidating rather than expanding. For the long term, the fundamentals appear sound enough to support a buy-and-hold thesis, given the strong year-over-year performance and the fact that the asset is no longer in a multi-year decline. The balance of risks and rewards tilts slightly positive, but the lack of a confirmed upward trend keeps the conviction moderate.